Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference
January 06 2023 - 9:43AM
Business Wire
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company,
will participate in the Biotech Showcase and Solebury 1x1
Management Access Conference, both happening alongside the J.P.
Morgan Healthcare Conference in San Francisco next week.
Eddie Martucci, Akili’s Co-Founder and Chief Executive Officer,
will represent the company and Digital Therapeutics Alliance (DTA)
as a panelist on the Biotech Showcase Future Panel: Digital
Therapeutics in The Next Decade, scheduled for January 11 at 12:00
p.m. (Eastern Time).
Company leaders will also meet with investors attending the J.P.
Morgan Healthcare Conference.
About Akili
Akili is pioneering the development of cognitive treatments
through game-changing technologies. Akili’s approach of leveraging
technologies designed to directly target the brain establishes a
new category of medicine – medicine that is validated through
clinical trials like a drug or medical device but experienced like
entertainment. Akili’s platform is powered by proprietary
therapeutic engines designed to target cognitive impairment at its
source in the brain, informed by decades of research and validated
through rigorous clinical programs. Driven by Akili’s belief that
effective medicine can also be fun and engaging, Akili’s products
are delivered through captivating action video game experiences.
For more information, please visit www.akiliinteractive.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230106005313/en/
Investors: Joshua Young VP, Investor Relations
jyoung@akiliinteractive.com
Media: Susannah Wesley-Ahlschwede VP, Communications
swesley@akiliinteractive.com
Akili (NASDAQ:AKLI)
Historical Stock Chart
From Apr 2024 to May 2024
Akili (NASDAQ:AKLI)
Historical Stock Chart
From May 2023 to May 2024